Alpha-2-macroglobulin (A2M)

Alpha-2-macroglobulin (A2M) is a large (720 kDa) plasma glycoprotein and a member of the macroglobulin family produced mainly by the liver, as well as by macrophages, fibroblasts, and adrenocortical cells[4]. It acts as a broad-spectrum protease inhibitor, entrapping a wide range of endopeptidases from all catalytic classes through a unique conformational ‘trap’ or ‘Venus flytrap’ mechanism, assisted by a thioester bond that forms a covalent link to target proteases[1][2][5]. Besides its key role in regulating proteolytic activity during inflammation, coagulation, and fibrinolysis, A2M binds and carries numerous cytokines, growth factors, and hormones, and may modulate signaling pathways related to immune response and cell proliferation[4][5]. Elevated serum concentrations are seen in nephrotic syndrome due to restricted renal excretion, and A2M-protease complexes may function in disease and as biomarkers[4]. The protein’s extensive substrate range, multifunctionality, and structural conservation across evolution reflect its fundamental importance in physiology and pathology[1][5].

Other names

α2-macroglobulinα2Malpha-2-macroglobulinA2-macroglobulinPregnancy zone protein (for closely related protein)PZP (for closely related protein)

Inhibits endopeptidases by physically entrapping them inside a protein complex (Venus flytrap or snap-trap mechanism), forming an irreversible covalent complex via a reactive thioester bond. Sequesters proteases, restricting access to large substrate molecules while allowing small peptides to enter. After modification, binds to cellular receptors (e.g., low-density lipoprotein receptor) for clearance[1][2][5].